Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Mar 21, 2023
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2023-03-17$21.78/sh−714$15,551→ 58,813 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]This transaction was executed in multiple trades in prices ranging from $21.4075 to $21.784581, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 49,600 RSUs.